Get the Stockscreener App
5.74
2.05%
-0.12
After Hours:
5.82
0.08
+1.39%
Alpha Cognition Inc stock is traded at $5.74, with a volume of 85,735.
It is down -2.05% in the last 24 hours and up +27.56% over the past month.
Alpha Cognition Inc is a biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer's disease, for which there are limited or no treatment options. The Company's current focus is on the commercial manufacturing and sales of ZUNVEYL oral tablet formulation. The Company's commercial development program for ZUNVEYL is primarily focused on building a long-term care commercial team that can focus on providing key points of differentiation, exploiting key issues with existing Acetylcholinesterase inhibitors treatments, and seeking potential licensing partners for other additional indications and new formulations.
See More
Previous Close:
$5.86
Open:
$5.88
24h Volume:
85,735
Relative Volume:
1.02
Market Cap:
$124.80M
Revenue:
-
Net Income/Loss:
$-14.72M
P/E Ratio:
-2.0283
EPS:
-2.83
Net Cash Flow:
$-7.41M
1W Performance:
-4.33%
1M Performance:
+27.56%
6M Performance:
-35.51%
1Y Performance:
-1.05%
1-Day Range:
$5.64
$6.29
1-Week Range:
$5.29
$6.29
52-Week Range:
$3.75
$11.54
Alpha Cognition Inc Stock (ACOG) Company Profile
Name
Alpha Cognition Inc
Sector
Industry
Phone
(858) 344-4375
Address
1200-750 W PENDER ST, VANCOUVER
Compare ACOG vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ACOG
Alpha Cognition Inc
|
5.74 | 127.41M | 0 | -14.72M | -7.41M | -2.83 |
|
VRTX
Vertex Pharmaceuticals Inc
|
460.82 | 121.40B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
764.93 | 83.25B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
728.11 | 46.39B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
320.51 | 43.41B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
292.94 | 33.09B | 5.36B | 287.73M | 924.18M | 2.5229 |
Alpha Cognition Inc Stock (ACOG) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-18-25 | Initiated | H.C. Wainwright | Buy |
Alpha Cognition Inc Stock (ACOG) Latest News
Major Investor Quietly Boosts Its Stake in This Emerging Biotech Player - TipRanks
Stock Recap: Can Alpha Cognition Inc deliver consistent dividends2025 Biggest Moves & Weekly Stock Performance Updates - baoquankhu1.vn
Major Investor Quietly Boosts Position in Emerging Biotech Player - TipRanks
Alpha Cognition (FRA:7N70) Cyclically Adjusted Price-to-FCF : (As of Mar. 01, 2026) - GuruFocus
Alpha Cognition Inc. (NASDAQ:ACOG) Short Interest Down 32.1% in February - MarketBeat
Alpha Cognition (FRA:7N70) Cyclically Adjusted PB Ratio : (As of Feb. 28, 2026) - GuruFocus
Opaleye Management Inc. Expands Stake in Alpha Cognition Inc. - GuruFocus
Block Trades: Will Alpha Cognition Inc outperform during market ralliesPortfolio Update Summary & Growth Oriented Trading Recommendations - baoquankhu1.vn
Is Alpha Cognition Inc. a strong candidate for buy and holdTrade Entry Report & Low Risk High Win Rate Stock Picks - mfd.ru
ACOG Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Alpha Cognition Announces First Patient Enrolled in BEACON Real-World Effectiveness Study - BioSpace
Alpha Cognition announces first patient enrolled in Beacon real-world effectiveness study - marketscreener.com
Major Investor Makes Bold Move on Alpha Cognition Stock - TipRanks
ACOGAlpha Cognition Latest Stock News & Market Updates - Stock Titan
Opaleye entities report 2.19M shares in Alpha Cognition (ACOG) filing - Stock Titan
Alpha Cognition secures patent for Alzheimer’s drug dosing regimens By Investing.com - Investing.com Canada
Alpha Cognition secures patent for Alzheimer’s drug dosing regimens - Investing.com Australia
Alpha Cognition Announces Issuance of Additional U.S. Patent Covering ZUNVEYL ® Dosing Regimens - BioSpace
Alpha Cognition Gets US Patent for Administration of Alzheimer's Treatment - marketscreener.com
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
Several Insiders Invested In Alpha Cognition Flagging Positive News - Yahoo Finance
Highs Report: Will Hancock Whitney Corporation benefit from rising consumer demandWeekly Loss Report & Consistent Growth Stock Picks - baoquankhu1.vn
How interest rate cuts could boost Alpha Cognition Inc. stockJuly 2025 Rallies & Community Trade Idea Sharing Platform - mfd.ru
Should I buy Alpha Cognition Inc. stock nowTrade Entry Report & Community Supported Trade Ideas - mfd.ru
Will Alpha Cognition Inc. stock continue upward momentum2025 AllTime Highs & Risk Controlled Stock Pick Alerts - mfd.ru
Alpha Cognition (NASDAQ:ACOG) Trading Up 13.3%Here's What Happened - MarketBeat
Setup Watch: Can Alpha Cognition Inc sustain its profitabilityWeekly Trade Review & AI Enhanced Trade Execution Alerts - baoquankhu1.vn
Moving Averages: Should I buy Alpha Cognition Inc stock nowTrade Analysis Summary & Long-Term Growth Portfolio Plans - baoquankhu1.vn
Inflation Data: How sensitive is ADNWW to inflationMarket Sentiment Report & Verified Momentum Stock Ideas - baoquankhu1.vn
Bull Bear: Does Alpha Cognition Inc have declining or rising EPSShort Setup & Safe Entry Point Identification - baoquankhu1.vn
Can Alpha Cognition Inc. continue delivering strong returns2025 Key Lessons & Growth Oriented Trading Recommendations - mfd.ru
Aug Reactions: Does Alpha Cognition Inc have declining or rising EPSJuly 2025 Selloffs & Advanced Swing Trade Entry Alerts - baoquankhu1.vn
A | Will Alpha Cognition Inc. benefit from geopolitical trendsJuly 2025 Retail & AI Enhanced Execution Alerts - mfd.ru
Whittier Daily News - FinancialContent
Insider Traders Lose US$128k As Alpha Cognition Drops - simplywall.st
Alpha Cognition Inc. (NASDAQ:ACOG) Short Interest Update - MarketBeat
Alpha Cognition grants equity awards to executive officers under 2025 plan - Investing.com Nigeria
Alpha Cognition grants equity awards to executive officers under 2025 plan By Investing.com - Investing.com South Africa
Market Wrap: Will Alpha Cognition Inc benefit from geopolitical trendsJuly 2025 Levels & Precise Swing Trade Alerts - baoquankhu1.vn
Aug Gainers: Will Alpha Cognition Inc stock attract more institutional investors2025 Technical Overview & Free Weekly Chart Analysis and Trade Guides - Bộ Nội Vụ
Sentiment Review: Can Alpha Cognition Inc stock double in the next yearRate Hike & Free Accurate Trade Setup Notifications - baoquankhu1.vn
Alpha Cognition prices $35M public offering of common shares - MSN
Why Alpha Cognition Inc. stock remains on watchlists2025 Bull vs Bear & AI Based Trade Execution Alerts - ulpravda.ru
Is Alpha Cognition Inc. stock supported by strong fundamentals2025 Market Trends & High Return Stock Watch Alerts - Улправда
Why Alpha Cognition Inc. stock could rally in 2025Index Update & Verified Momentum Stock Alerts - Улправда
What margin trends mean for Alpha Cognition Inc. stock2025 Sector Review & Daily Momentum Trading Reports - Улправда
Alpha Cognition Provides 2026 Corporate Update Highlighting Strategic Priorities and 2025 Commercial Execution - BioSpace
Alpha Cognition provides 2026 corporate update highlighting strategic priorities and 2025 commercial execution - marketscreener.com
Alpha Cognition Provides 2026 Corporate Update Highlighting Strategic Priorities And 2025 Commercial Execution - TradingView — Track All Markets
Published on: 2026-01-08 02:14:38 - moha.gov.vn
Hedge funds own 20% of Alpha Cognition Inc. (NASDAQ:ACOG) shares but individual investors control 53% of the company - Yahoo Finance
Alpha Cognition Inc Stock (ACOG) Financials Data
Revenue
Net Income
Cash Flow
EPS
Alpha Cognition Inc Stock (ACOG) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Opaleye Management Inc. | 10% Owner |
Mar 02 '26 |
Buy |
5.80 |
20,000 |
116,000 |
2,308,638 |
| Opaleye Management Inc. | 10% Owner |
Feb 27 '26 |
Buy |
5.99 |
3,638 |
21,797 |
2,288,638 |
| Opaleye Management Inc. | 10% Owner |
Feb 26 '26 |
Buy |
5.99 |
590 |
3,531 |
2,285,000 |
| Opaleye Management Inc. | 10% Owner |
Feb 23 '26 |
Buy |
5.89 |
100,000 |
589,230 |
2,230,819 |
| Opaleye Management Inc. | 10% Owner |
Feb 24 '26 |
Buy |
5.80 |
58,591 |
339,851 |
2,284,410 |
| Opaleye Management Inc. | 10% Owner |
Feb 20 '26 |
Buy |
5.84 |
12,819 |
74,877 |
2,135,000 |
| Wills Robert James | Director |
Aug 18 '25 |
Buy |
8.49 |
15,000 |
127,328 |
15,000 |
| MERTZ PHILLIP JOSEPH | Director |
Aug 18 '25 |
Sale |
9.00 |
27,778 |
250,002 |
22,462 |
| MERTZ LEONARD POWELL | Director |
Aug 18 '25 |
Buy |
9.00 |
27,778 |
250,002 |
121,503 |
3.69%
0.68%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):